Form 4: Shuttle Pharmaceuticals Holdings, Inc. Insider Trading Activity

Sentiment:

Statement of Changes in Beneficial Ownership


HRT FINANCIAL LP reports significant stock transactions in Shuttle Pharmaceuticals Holdings, Inc., indicating changes in beneficial ownership.

Summary

  • HRT FINANCIAL LP, a 10% owner and director of Shuttle Pharmaceuticals Holdings, Inc. (SHPH), has reported several transactions involving the company's common stock.
  • On June 29, 2026, the earliest transaction date noted, HRT FINANCIAL LP acquired 7,851 shares of common stock at a price of $3.54 per share.
  • Following this acquisition, HRT FINANCIAL LP disposed of 9,022 shares of common stock on July 6, 2026, at a price of $3.51 per share.
  • As of the reported transactions, HRT FINANCIAL LP beneficially owns 81,385 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it reports routine insider transactions (both acquisition and disposal) without providing new strategic information or financial performance data.

Positives

  • Acquisition of 7,851 shares by HRT FINANCIAL LP, a significant stakeholder, suggests continued confidence or strategic adjustment.
  • The acquisition price of $3.54 per share may represent a favorable entry or addition point for the reporting person.

Negatives

  • Disposal of 9,022 shares by HRT FINANCIAL LP indicates a reduction in their direct holdings.
  • The disposal price of $3.51 per share is slightly lower than the acquisition price, suggesting a minor realized loss on the disposed shares.

Future Outlook

No specific forward-looking statements or guidance are provided in this Form 4 filing, which primarily reports past transactions.

Industry Context

StockSavvy.ai notes that Form 4 filings are crucial for understanding insider activity, which can provide signals about management's perception of the company's value and future prospects. Significant transactions by 10% owners like HRT FINANCIAL LP warrant close observation by investors.

Stakeholder Impact

  • Shareholders may interpret the acquisition as a positive signal of confidence from a major stakeholder, while the disposal might be seen as a signal of reduced conviction or a need for liquidity.
  • The net change in holdings by HRT FINANCIAL LP could influence market perception of the stock's immediate direction.

Key Dates

DateDescription
06/29/2026Earliest transaction date reported.
07/02/2026Transaction date for acquisition of 7,851 shares.
07/06/2026Transaction date for disposal of 9,022 shares.
07/07/2026Signature date of the reporting person.

Keywords

Form 4, SEC Filing, Insider Trading, Beneficial Ownership, Stock Transactions, Shuttle Pharmaceuticals Holdings, HRT FINANCIAL LP, Common Stock, Equity Securities

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.